Supporting read-across using biological data.

Read-across, i.e. filling toxicological data gaps by relating to similar chemicals, for which test data are available, is usually done based on chemical similarity. Besides structure and physico-chemical properties, however, biological similarity based on biological data adds extra strength to this process. In the context of developing Good Read-Across Practice guidance, a number of case studies were evaluated to demonstrate the use of biological data to enrich read-across. In the simplest case, chemically similar substances also show similar test results in relevant in vitro assays. This is a well-established method for the read-across of e.g. genotoxicity assays. Larger datasets of biological and toxicological properties of hundreds and thousands of substances become increasingly available enabling big data approaches in read-across studies. Several case studies using various big data sources are described in this paper. An example is given for the US EPA's ToxCast dataset allowing read-across for high quality uterotrophic assays for estrogenic endocrine disruption. Similarly, an example for REACH registration data enhancing read-across for acute toxicity studies is given. A different approach is taken using omics data to establish biological similarity: Examples are given for stem cell models in vitro and short-term repeated dose studies in rats in vivo to support read-across and category formation. These preliminary biological data-driven read-across studies highlight the road to the new generation of read-across approaches that can be applied in chemical safety assessment.

[1]  L. Smirnova,et al.  Metabolomics in toxicology and preclinical research. , 2013, ALTEX.

[2]  Alexandra Maertens,et al.  Analysis of Public Oral Toxicity Data from REACH Registrations 2008–2014 , 2016, ALTEX.

[3]  A. Hubbard,et al.  Toxicogenomic profiling of chemically exposed humans in risk assessment. , 2010, Mutation research.

[4]  Pierre R. Bushel,et al.  CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data , 2007, Nucleic Acids Res..

[5]  M. van den Berg,et al.  Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells. , 2010, Toxicology letters.

[6]  Alexander Golbraikh,et al.  Integrative chemical-biological read-across approach for chemical hazard classification. , 2013, Chemical research in toxicology.

[7]  Mark T. D. Cronin,et al.  The present status of QSAR in toxicology , 2003 .

[8]  Bas J Blaauboer,et al.  The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans. , 2012, ALTEX.

[9]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[10]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database's 10th year anniversary: update 2015 , 2014, Nucleic Acids Res..

[11]  M T D Cronin,et al.  Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[12]  David M. Reif,et al.  Aggregating Data for Computational Toxicology Applications: The U.S. Environmental Protection Agency (EPA) Aggregated Computational Toxicology Resource (ACToR) System , 2012, International journal of molecular sciences.

[13]  David M. Reif,et al.  In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.

[14]  Aldert H Piersma,et al.  Evaluation of an alternative in vitro test battery for detecting reproductive toxicants in a grouping context. , 2015, Reproductive toxicology.

[15]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[16]  Alexander Amberg,et al.  EU framework 6 project: predictive toxicology (PredTox)--overview and outcome. , 2011, Toxicology and applied pharmacology.

[17]  Thomas Hartung,et al.  Integrated Testing Strategies (ITS) for safety assessment. , 2015, ALTEX.

[18]  D. Dix,et al.  The ToxCast program for prioritizing toxicity testing of environmental chemicals. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Daniel P. Russo,et al.  Global Analysis of Publicly Available Safety Data for 9,801 Substances Registered under REACH from 2008–2014 , 2016, ALTEX.

[20]  H. Kamp,et al.  The individual and combined metabolite profiles (metabolomics) of dibutylphthalate and di(2-ethylhexyl)phthalate following a 28-day dietary exposure in rats. , 2010, Toxicology letters.

[21]  Richard A Becker,et al.  Read-across approaches--misconceptions, promises and challenges ahead. , 2014, ALTEX.

[22]  M. Fielden,et al.  Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. , 2005, Journal of biotechnology.

[23]  H. Kamp,et al.  Metabolomics: a tool for early detection of toxicological effects and an opportunity for biology based grouping of chemicals-from QSAR to QBAR. , 2012, Mutation research.

[24]  Thomas Hartung,et al.  Review: Toxicometabolomics , 2013, Journal of applied toxicology : JAT.

[25]  Alexandra Maertens,et al.  Analysis of Publically Available Skin Sensitization Data from REACH Registrations 2008–2014 , 2016, ALTEX.

[26]  Emilio Benfenati,et al.  The ToxBank Data Warehouse: Supporting the Replacement of In Vivo Repeated Dose Systemic Toxicity Testing , 2013, Molecular informatics.

[27]  Hao Zhu,et al.  Big Data in Chemical Toxicity Research: The Use of High-Throughput Screening Assays To Identify Potential Toxicants , 2014, Chemical research in toxicology.

[28]  Herbert S. Rosenkranz,et al.  Multiple Computer‐Automated structure evaluation program study of aquatic toxicity 1: Guppy , 1999 .

[29]  Sieto Bosgra,et al.  Interpreting in vitro developmental toxicity test battery results: The consideration of toxicokinetics. , 2015, Reproductive toxicology.

[30]  R. Trethewey,et al.  Metabolite Profiling with GC-MS and LC-MS , 2005 .

[31]  Aldert H Piersma,et al.  Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  A H Piersma,et al.  Evaluation of an alternative in vitro test battery for detecting reproductive toxicants. , 2013, Reproductive toxicology.

[33]  H. Kamp,et al.  Influence of strain and sex on the metabolic profile of rats in repeated dose toxicological studies. , 2009, Toxicology letters.

[34]  Valérie Zuang,et al.  A Modular Approach to the ECVAM Principles on Test Validity , 2004, Alternatives to laboratory animals : ATLA.

[35]  Hilda Witters,et al.  The ReProTect Feasibility Study, a novel comprehensive in vitro approach to detect reproductive toxicants. , 2010, Reproductive toxicology.

[36]  Judy Strickland,et al.  A Curated Database of Rodent Uterotrophic Bioactivity , 2015, Environmental health perspectives.

[37]  Mardas Daneshian,et al.  Consensus report on the future of animal-free systemic toxicity testing. , 2014, ALTEX.

[38]  H. Kamp,et al.  Nutritional impact on the plasma metabolome of rats. , 2011, Toxicology letters.

[39]  David M. Reif,et al.  Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays , 2013, Chemical research in toxicology.

[40]  Naomie Salim,et al.  Similarity‐Based Virtual Screening with a Bayesian Inference Network , 2009, ChemMedChem.

[41]  T. Insel,et al.  NIH Molecular Libraries Initiative , 2004, Science.

[42]  G. Klopman,et al.  Searching for an Enhanced Predictive Tool for Mutagenicity , 2004, SAR and QSAR in environmental research.

[43]  Elke Genschow,et al.  Embryotoxicity Screening Using Embryonic Stem Cells in vitro: Correlation to in vivo Teratogenicity , 1999, Cells Tissues Organs.

[44]  Alexandra Maertens,et al.  Integrated testing strategies for safety assessments. , 2013, ALTEX.

[45]  Russell S. Thomas,et al.  Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[46]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[47]  H. Kamp,et al.  Mechanistic analysis of metabolomics patterns in rat plasma during administration of direct thyroid hormone synthesis inhibitors or compounds increasing thyroid hormone clearance. , 2014, Toxicology letters.

[48]  Alexandra Maertens,et al.  t4 Workshop Report , 2017, ALTEX.

[49]  M. Schwarz,et al.  Prediction of embryotoxic potential using the ReProGlo stem cell-based Wnt reporter assay. , 2015, Reproductive toxicology.

[50]  J. Hengstler,et al.  The REACH concept and its impact on toxicological sciences. , 2006, Toxicology.

[51]  Nicole C. Kleinstreuer,et al.  Disruption of embryonic vascular development in predictive toxicology. , 2011, Birth defects research. Part C, Embryo today : reviews.

[52]  H. Yamada,et al.  The Japanese toxicogenomics project: application of toxicogenomics. , 2010, Molecular nutrition & food research.

[53]  Hennicke Kamp,et al.  The Use of Metabolomics in Cancer Research , 2010 .

[54]  Hao Zhu,et al.  Profiling Animal Toxicants by Automatically Mining Public Bioassay Data: A Big Data Approach for Computational Toxicology , 2014, PloS one.

[55]  Abraham Brouwer,et al.  Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[56]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[57]  George Daston,et al.  Framework for identifying chemicals with structural features associated with the potential to act as developmental or reproductive toxicants. , 2013, Chemical research in toxicology.

[58]  Ruili Huang,et al.  Mechanism Profiling of Hepatotoxicity Caused by Oxidative Stress Using Antioxidant Response Element Reporter Gene Assay Models and Big Data , 2015, Environmental health perspectives.

[59]  David M. Reif,et al.  Environmental Impact on Vascular Development Predicted by High-Throughput Screening , 2011, Environmental health perspectives.

[60]  Kellyn S. Betts,et al.  Tox21 to Date: Steps toward Modernizing Human Hazard Characterization , 2013, Environmental health perspectives.

[61]  Melvin E. Andersen,et al.  Integrating pathway-based transcriptomic data into quantitative chemical risk assessment: a five chemical case study. , 2012, Mutation research.

[62]  Thomas Hartung,et al.  Food for thought ... on alternative methods for cosmetics safety testing. , 2008, ALTEX.

[63]  Dimitar Hristozov,et al.  Development of new COSMOS oRepeatDose and non-cancer Threshold of Toxicological Concern (TTC) databases to support alternative testing methods for cosmetics related chemicals , 2013 .

[64]  Hao Zhu,et al.  Analysis of Draize Eye Irritation Testing and its Prediction by Mining Publicly Available 2008–2014 REACH Data , 2016, ALTEX.

[65]  Michael C. Rosenstein,et al.  The comparative toxicogenomics database: a cross-species resource for building chemical-gene interaction networks. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[66]  Alexander Tropsha,et al.  Quantitative structure-activity relationship modeling of rat acute toxicity by oral exposure. , 2009, Chemical research in toxicology.

[67]  E. Kroese,et al.  Towards a pragmatic alternative testing strategy for the detection of reproductive toxicants. , 2011, Reproductive toxicology.

[68]  A. Piersma,et al.  A different approach to validating screening assays for developmental toxicity. , 2010, Birth defects research. Part B, Developmental and reproductive toxicology.

[69]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[70]  David M. Reif,et al.  Endocrine Profiling and Prioritization of Environmental Chemicals Using ToxCast Data , 2010, Environmental health perspectives.

[71]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Imran Shah,et al.  Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  Philip Wexler,et al.  Toxnet: A computerized collection of toxicological and environmental health information , 2000, Toxicology and industrial health.

[74]  Michael C. Rosenstein,et al.  The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. , 2006, Journal of experimental zoology. Part A, Comparative experimental biology.

[75]  Thomas Hartung,et al.  Pathways of Toxicity. , 2014, ALTEX.

[76]  Markus Hecker,et al.  The OECD validation program of the H295R steroidogenesis assay: Phase 3. Final inter-laboratory validation study , 2011, Environmental science and pollution research international.

[77]  Michael C. Rosenstein,et al.  Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD) , 2004, The Pharmacogenomics Journal.

[78]  Sebastian Hoffmann,et al.  Food for thought ... on in silico methods in toxicology. , 2009, ALTEX.

[79]  Mathieu Vinken,et al.  The adverse outcome pathway concept: a pragmatic tool in toxicology. , 2013, Toxicology.

[80]  Igor V. Tetko,et al.  Combinatorial QSAR Modeling of Chemical Toxicants Tested against Tetrahymena pyriformis , 2008, J. Chem. Inf. Model..

[81]  T. Hartung Food for thought ... on validation. , 2007, ALTEX.

[82]  Erwin van Vliet,et al.  Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century. , 2011 .

[83]  Evan Bolton,et al.  An overview of the PubChem BioAssay resource , 2009, Nucleic Acids Res..

[84]  R. Burrier,et al.  Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening. , 2013, Birth defects research. Part B, Developmental and reproductive toxicology.

[85]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[86]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[87]  Marlene T. Kim,et al.  Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs by Using Various Cheminformatics Approaches , 2013, Pharmaceutical Research.

[88]  David M. Reif,et al.  Toxicity Testing in the 21st Century Beyond Environmental Chemicals , 2018, ALTEX.

[89]  M. Badr,et al.  Extraperoxisomal targets of peroxisome proliferators: mitochondrial, microsomal, and cytosolic effects. Implications for health and disease. , 1998, Critical reviews in toxicology.

[90]  Robert J Kavlock,et al.  Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.

[91]  Igor Linkov,et al.  From "Weight of Evidence" to Quantitative Data Integration using Multicriteria Decision Analysis and Bayesian Methods , 2015, ALTEX.

[92]  Ruili Huang,et al.  The pilot phase of the NIH Chemical Genomics Center. , 2009, Current topics in medicinal chemistry.

[93]  T. Vanhaecke,et al.  Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients , 2012, Archives of Toxicology.

[94]  Marlene T. Kim,et al.  Developing Enhanced Blood–Brain Barrier Permeability Models: Integrating External Bio-Assay Data in QSAR Modeling , 2015, Pharmaceutical Research.

[95]  H. Kamp,et al.  The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective. , 2014, Toxicology letters.

[96]  H. Kamp,et al.  Reproducibility and robustness of metabolome analysis in rat plasma of 28-day repeated dose toxicity studies. , 2012, Toxicology letters.

[97]  C. Mattingly,et al.  The Comparative Toxicogenomics Database (CTD). , 2003, Environmental health perspectives.

[98]  Marlene T. Kim,et al.  Predicting chemical ocular toxicity using a combinatorial QSAR approach. , 2012, Chemical research in toxicology.

[99]  Hao Zhu,et al.  t4 report*: Toward Good Read-Across Practice (GRAP) Guidance , 2016, ALTEX.

[100]  Ann Richard,et al.  ACToR--Aggregated Computational Toxicology Resource. , 2008, Toxicology and applied pharmacology.